These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29366968)

  • 1. Report of two cases of tocilizumab induced recurrent meningitis or meningoencephalitis.
    Richebé P; Bailly F; Mariani LL; Pena PS; Pedespan JM; Fautrel B
    Joint Bone Spine; 2018 Oct; 85(5):643-644. PubMed ID: 29366968
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical juxta-articular form of Dercum's disease in a patient treated with tocilizumab for rheumatoid arthritis.
    Baudart P; Cesini J; Marcelli C
    Joint Bone Spine; 2018 Oct; 85(5):629-630. PubMed ID: 29198885
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration.
    Ahmed M; Luggen M; Herman JH; Weiss KL; Decourten-Myers G; Quinlan JG; Khanna D
    J Rheumatol; 2006 Nov; 33(11):2344-6. PubMed ID: 16981287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis onset with tocilizumab treatment for rheumatoid arthritis.
    Wendling D; Letho-Gyselinck H; Guillot X; Prati C
    J Rheumatol; 2012 Mar; 39(3):657. PubMed ID: 22383356
    [No Abstract]   [Full Text] [Related]  

  • 5. A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B.
    Tsuboi H; Tsujii A; Nampei A; Yoshihara H; Kawano K; Takeuchi E; Shi K
    Mod Rheumatol; 2011 Dec; 21(6):701-5. PubMed ID: 21626075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crisaborole, Dupilumab, and Sarilumab.
    Hussar DA; Lee YF
    J Am Pharm Assoc (2003); 2017; 57(5):640-643. PubMed ID: 28882252
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin 6 blockade-associated weight gain with abdominal enlargement in a patient with rheumatoid arthritis.
    Younis S; Rosner I; Rimar D; Boulman N; Rozenbaum M; Odeh M; Slobodin G
    J Clin Rheumatol; 2013 Jan; 19(1):48-9. PubMed ID: 23319026
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic drug-induced liver failure during therapy of rheumatoid arthritis with tocilizumab subcutaneously: a case report.
    Anger F; Wiegering A; Wagner J; Lock J; Baur J; Haug L; Schmalzing M; Geier A; Löb S; Klein I
    Rheumatology (Oxford); 2017 Sep; 56(9):1628-1629. PubMed ID: 28575416
    [No Abstract]   [Full Text] [Related]  

  • 9. Aseptic meningitis possibly induced by adalimumab.
    Jazeron A; Lallier JC; Rihn B; Thiercelin MC
    Joint Bone Spine; 2010 Dec; 77(6):618-9. PubMed ID: 20656540
    [No Abstract]   [Full Text] [Related]  

  • 10. Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
    Nishimoto N; Amano K; Hirabayashi Y; Horiuchi T; Ishii T; Iwahashi M; Iwamoto M; Kohsaka H; Kondo M; Matsubara T; Mimura T; Miyahara H; Ohta S; Saeki Y; Saito K; Sano H; Takasugi K; Takeuchi T; Tohma S; Tsuru T; Ueki Y; Yamana J; Hashimoto J; Matsutani T; Murakami M; Takagi N
    Mod Rheumatol; 2014 Jan; 24(1):26-32. PubMed ID: 24261755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent hepatotoxicity associated with etanercept and adalimumab but not with infliximab in a patient with rheumatoid arthritis.
    Titos Arcos JC; Hallal H; Robles M; Andrade RJ
    Rev Esp Enferm Dig; 2012 May; 104(5):282-4. PubMed ID: 22662786
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab.
    Honda H; Kida H; Yoshida M; Tomita T; Fujii M; Ihara S; Goya S; Tachibana I; Kawase I
    Mod Rheumatol; 2011 Dec; 21(6):660-4. PubMed ID: 21472474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous rash from the use of medicine for rheumatoid arthritis].
    Hannuksela M
    Duodecim; 2006; 122(1):105, 111. PubMed ID: 16509198
    [No Abstract]   [Full Text] [Related]  

  • 14. Tocilizumab-induced immune complex glomerulonephritis in a patient with rheumatoid arthritis.
    Matsuo Y; Mizoguchi F; Kohsaka H; Ito E; Eishi Y; Miyasaka N
    Rheumatology (Oxford); 2013 Jul; 52(7):1341-3. PubMed ID: 23325036
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
    Fechtenbaum M; Banse C; Boyard-Lasselin P; Goëb V
    Joint Bone Spine; 2015 Jan; 82(1):69-70. PubMed ID: 25048098
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approves tocilizumab to treat rheumatoid arthritis.
    Thompson CA
    Am J Health Syst Pharm; 2010 Feb; 67(4):254. PubMed ID: 20133526
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hepatitis associated with tocilizumab in a patient with rheumatoid arthritis.
    Alfreijat M; Habibi M; Bhatia P; Bhatia A
    Rheumatology (Oxford); 2013 Jul; 52(7):1340-1. PubMed ID: 23315786
    [No Abstract]   [Full Text] [Related]  

  • 18. Tocilizumab-associated cutaneous reactive endotheliomatosis in a patient with rheumatoid arthritis.
    Wu CP; Hsieh CW; Chen DY; Lee BJ; Yang CS
    Joint Bone Spine; 2015 Mar; 82(2):132-4. PubMed ID: 25553831
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks.
    Yokoe I; Nishio S; Sato H; Kobayashi H
    Mod Rheumatol; 2011 Dec; 21(6):710-4. PubMed ID: 21656090
    [No Abstract]   [Full Text] [Related]  

  • 20. Tocilizumab (Actemra) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2010 Jun; 52(1340):47-8. PubMed ID: 20539266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.